-
Full Article (HTML) (36) -
Full Article (PDF) (8)
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3067)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2013 (publication date) through Jul 5, 2020
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Yihebali Chi, Feng Du, Hong Zhao, Jin-Wan Wang, Jian-Qiang Cai. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors. World Journal of Gastroenterology 2014; 20(43): 16252-16257 doi: 10.3748/wjg.v20.i43.16252
|
| 2 |
J. Eick, J. Steinberg, C. Schwertner, W. Ring, H. Scherübl. Neuroendokrine Tumoren des Rektums: endoskopische Therapie. Der Chirurg 2016; 87(4): 288 doi: 10.1007/s00104-015-0141-6
|
| 3 |
K. Holzer. Gastroenteropankreatische neuroendokrine Tumoren. Der Chirurg 2014; 85(8): 731 doi: 10.1007/s00104-013-2679-5
|
| 4 |
Valentina Ambrosini, Davide Campana, Cristina Nanni, Maria Cristina Marzola, Domenico Rubello, Stefano Fanti. 68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. Clinical Nuclear Medicine 2015; 40(2): e132 doi: 10.1097/RLU.0000000000000447
|
| 5 |
Emilio Bertani, Davide Ravizza, Massimo Milione, Sara Massironi, Chiara Maria Grana, Dario Zerini, Alessandra Nella Piccioli, Giuseppe Spinoglio, Nicola Fazio. Neuroendocrine neoplasms of rectum: A management update. Cancer Treatment Reviews 2018; 66: 45 doi: 10.1016/j.ctrv.2018.04.003
|
| 6 |
B. C. Kim, Y. E. Kim, H. J. Chang, S. H. Lee, E. G. Youk, D.-S. Lee, J. B. Lee, E.-J. Lee, M. J. Kim, D. K. Sohn, J. H. Oh. Lymph node size is not a reliable criterion for predicting nodal metastasis in rectal neuroendocrine tumours. Colorectal Disease 2016; 18(7): O243 doi: 10.1111/codi.13377
|
| 7 |
Tiffany J. Sinclair, George A. Poultsides. Islet Tumors. Advances in Surgery 2020; doi: 10.1016/j.yasu.2020.04.004
|
| 8 |
George C. Nikou, Kalliopi Pazaitou-Panayiotou, Dimitrios Dimitroulopoulos, Georgios Alexandrakis, Pavlos Papakostas, Michalis Vaslamatzis, Philippos Kaldrymidis, Vyron Markussis, Anna Koumarianou. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients. BMC Endocrine Disorders 2016; 16(1) doi: 10.1186/s12902-016-0089-7
|
| 9 |
Mengjie Jiang, Yinuo Tan, Xiaofen Li, Jianfei Fu, Hanguang Hu, Xianyun Ye, Ying Cao, Jinghong Xu, Ying Yuan. Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/4206172
|
| 10 |
Marco Gallo, Pasqualino Malandrino, Giuseppe Fanciulli, Francesca Rota, Antongiulio Faggiano, Annamaria Colao. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives. Journal of Cancer Research and Clinical Oncology 2017; 143(7): 1209 doi: 10.1007/s00432-017-2407-5
|
| 11 |
Shunda Du, Zi Wang, Xinting Sang, Xin Lu, Yongchang Zheng, Haifeng Xu, Yiyao Xu, Tianyi Chi, Haitao Zhao, Wenze Wang, Quancai Cui, Shouxian Zhong, Jiefu Huang, Yilei Mao. Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases. Medicine 2015; 94(2): e388 doi: 10.1097/MD.0000000000000388
|
| 12 |
Andrea Mafficini, Aldo Scarpa. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms. Endocrine Reviews 2019; 40(2): 506 doi: 10.1210/er.2018-00160
|
| 13 |
ZHIQIANG WANG, WENLIANG LI, TIANXING CHEN, JUN YANG, LILIN LUO, LIANYU ZHANG, BAOCUN SUN, RUI LIANG. Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms. Experimental and Therapeutic Medicine 2015; 10(3): 1084 doi: 10.3892/etm.2015.2634
|
| 14 |
Aaron I. Vinik, Edward M. Wolin, Nilani Liyanage, Edda Gomez-Panzani, George A. Fisher. EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Endocrine Practice 2016; 22(9): 1068 doi: 10.4158/EP151172.OR
|
| 15 |
Emanuele Leoncini, Paolo Boffetta, Michail Shafir, Katina Aleksovska, Stefania Boccia, Guido Rindi. Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms. Endocrine 2017; 58(2): 368 doi: 10.1007/s12020-017-1273-x
|
| 16 |
Wojciech Błogowski, Anna Madej-Michniewicz, Natalia Marczuk, Barbara Dołęgowska, Teresa Starzyńska. Interleukins 17 and 23 in patients with gastric neoplasms. Scientific Reports 2016; 6(1) doi: 10.1038/srep37451
|
| 17 |
Arthur I Kooyker, Wieke HM Verbeek, José G van den Berg, Margot ET Tesselaar, Monique E van Leerdam. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade. United European Gastroenterology Journal 2020; 8(1): 59 doi: 10.1177/2050640619865113
|
| 18 |
Nupur K. Purohit, Rashmi G. Shah, Samuel Adant, Michael Hoepfner, Girish M. Shah, Jean-Mathieu Beauregard. Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor. Oncotarget 2018; 9(37): 24693 doi: 10.18632/oncotarget.25266
|
| 19 |
E. Leoncini, G. Carioli, C. La Vecchia, S. Boccia, G. Rindi. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Annals of Oncology 2016; 27(1): 68 doi: 10.1093/annonc/mdv505
|
| 20 |
Qin Zhang, Cheng-Jun Lu, Xiang Zhang, Zhe Ma, Qi Xin, Chuan-Shan Zhang. Neuroendocrine Neoplasms of the Major Duodenal Papilla With Focus on Histopathological Features and Prognosis. International Journal of Surgical Pathology 2015; 23(6): 433 doi: 10.1177/1066896915586808
|
| 21 |
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie. 2017; : 1 doi: 10.1007/978-3-662-49083-9_30-1
|
| 22 |
Fara Uccelli, F. Gavazzi, G. Capretti, M. Virdis, M. Montorsi, A. Zerbi. Parenchyma-sparing surgery for pancreatic endocrine tumors. Updates in Surgery 2016; 68(3): 313 doi: 10.1007/s13304-016-0400-1
|
| 23 |
Ashwini Kalshetty, Anant Ramaswamy, Vikas Ostwal, Sandip Basu. Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors. Nuclear Medicine Communications 2018; 39(12): 1143 doi: 10.1097/MNM.0000000000000926
|
| 24 |
Henning Dralle, Phuong Nguyen Thanh, Andreas Machens. The Pancreas. 2018; : 982 doi: 10.1002/9781119188421.ch130
|
| 25 |
Lior H. Katz, Zohar Levi, Gilad Twig, Jeremy D. Kark, Adi Leiba, Estela Derazne, Irena Liphshiz, Lital Keinan-Boker, Sapir Eisenstein, Arnon Afek. Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescents. International Journal of Cancer 2018; 143(8): 1876 doi: 10.1002/ijc.31589
|
| 26 |
H. Scherübl, F. Raue, K. Frank-Raue. Neuroendokrine Tumoren. Der Radiologe 2019; 59(11): 952 doi: 10.1007/s00117-019-0574-x
|
| 27 |
Henning Dralle, Phuong Nguyen Thanh, Andreas Machens. The Pancreas. 2018; : 994 doi: 10.1002/9781119188421.ch132
|
| 28 |
Cheng Fang, Wei Wang, Yu Zhang, Xingyu Feng, Jian Sun, Yujie Zeng, Ye Chen, Yong Li, Minhu Chen, Zhiwei Zhou, Jie Chen. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China. Chinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0218-3
|
| 29 |
Barbara Altieri, Luigi Barrea, Roberta Modica, Giovanna Muscogiuri, Silvia Savastano, Annamaria Colao, Antongiulio Faggiano. Nutrition and neuroendocrine tumors: An update of the literature. Reviews in Endocrine and Metabolic Disorders 2018; 19(2): 159 doi: 10.1007/s11154-018-9466-z
|
| 30 |
Monika Szeliga, Jarosław Ćwikła, Marta Obara-Michlewska, Andrzej Cichocki, Jan Albrecht. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform. Experimental and Molecular Pathology 2016; 100(1): 74 doi: 10.1016/j.yexmp.2015.11.017
|
| 31 |
Federica Cavalcoli, Aoife Garrahy, Marco Castellaneta, Gianluca Tamagno. Neuroendocrine Tumors in Real Life. 2018; : 3 doi: 10.1007/978-3-319-59024-0_1
|
| 32 |
Peter E. Goretzki, Martina T. Mogl, Aycan Akca, Johann Pratschke. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract. Reviews in Endocrine and Metabolic Disorders 2018; 19(2): 169 doi: 10.1007/s11154-018-9469-9
|
| 33 |
Aldo Scarpa. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours. Annales d'Endocrinologie 2019; 80(3): 153 doi: 10.1016/j.ando.2019.04.010
|
| 34 |
Wojciech Błogowski, Ewa Zuba-Surma, Daria Sałata, Marta Budkowska, Barbara Dołęgowska, Teresa Starzyńska. Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasms. OncoImmunology 2016; 5(4): e1099798 doi: 10.1080/2162402X.2015.1099798
|
| 35 |
Andrea Mafficini, Aldo Scarpa. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium. Journal of Endocrinology 2018; 236(3): R161 doi: 10.1530/JOE-17-0560
|
| 36 |
Riccardo Ariotti, Stefano Partelli, Francesca Muffatti, Valentina Andreasi, Francesca Della Sala, Massimo Falconi. How should incidental NEN of the pancreas and gastrointestinal tract be followed?. Reviews in Endocrine and Metabolic Disorders 2018; 19(2): 139 doi: 10.1007/s11154-018-9445-4
|
| 37 |
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie. 2018; : 381 doi: 10.1007/978-3-662-48727-3_30
|
| 38 |
Kira Oleinikov, Alain Dancour, Julia Epshtein, Ariel Benson, Haggi Mazeh, Ilanit Tal, Shay Matalon, Carlos A Benbassat, Dan M Livovsky, Eran Goldin, David J Gross, Harold Jacob, Simona Grozinsky-Glasberg. Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors. The Journal of Clinical Endocrinology & Metabolism 2019; 104(7): 2637 doi: 10.1210/jc.2019-00282
|
| 39 |
K. Passek, N. Zulauf, M. H. Bendels, M. Braun, G. M. Oremek. Der Tumormarker Serotonin. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 2019; 69(5): 306 doi: 10.1007/s40664-018-0319-0
|
| 40 |
Giovanna Muscogiuri, Barbara Altieri, Manuela Albertelli, Andrea Dotto, Roberta Modica, Luigi Barrea, Giuseppe Fanciulli, Tiziana Feola, Roberto Baldelli, Rosaria Maddalena Ruggeri, Marco Gallo, Valentina Guarnotta, Pasqualino Malandrino, Erika Messina, Mary Anna Venneri, Elisa Giannetta, Diego Ferone, Annamaria Colao, Antongiulio Faggiano. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective. Endocrine 2020; doi: 10.1007/s12020-020-02331-3
|
| 41 |
Valentina Ambrosini, Stefano Fanti. Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors. 2017; : 351 doi: 10.1007/978-3-319-46038-3_16
|
| 42 |
Aman Chauhan, Qian Yu, Neha Ray, Zainab Farooqui, Bin Huang, Eric B. Durbin, Thomas Tucker, Mark Evers, Susanne Arnold, Lowell B. Anthony. Global burden of neuroendocrine tumors and changing incidence in Kentucky. Oncotarget 2018; 9(27): 19245 doi: 10.18632/oncotarget.24983
|
| 43 |
H. Azam-Zangeneh, M. Müller-Schilling, A. Kandulski. Neuroendokrine Neoplasien des Magens. Der Gastroenterologe 2018; 13(2): 126 doi: 10.1007/s11377-018-0231-3
|
| 44 |
Frediano Inzani, Gianluigi Petrone, Guido Rindi. Pancreatic Neuroendocrine Neoplasms. 2015; : 51 doi: 10.1007/978-3-319-17235-4_6
|
| 45 |
Saadettin Kilickap, Kadir Mutlu Hayran. Neuroendocrine Tumours. 2015; : 23 doi: 10.1007/978-3-662-45215-8_3
|
| 46 |
Miral Sadaria Grandhi, Kelly J. Lafaro, Timothy M. Pawlik. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 2015; 19(12): 2273 doi: 10.1007/s11605-015-2931-z
|
| 47 |
Anna Madej-Michniewicz, Marta Budkowska, Daria Sałata, Barbara Dołęgowska, Teresa Starzyńska, Wojciech Błogowski. Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary report. Scientific Reports 2015; 5(1) doi: 10.1038/srep14382
|
| 48 |
Ioannis Mintziras, Tobias Keck, Jens Werner, Stefan Fichtner-Feigl, Uwe Wittel, Norbert Senninger, Thorsten Vowinkel, Jörg Köninger, Matthias Anthuber, Bernd Geißler, Detlef Klaus Bartsch. Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry. World Journal of Surgery 2019; 43(1): 175 doi: 10.1007/s00268-018-4751-2
|
| 49 |
Margarita Ptasnuka, Arturs Ozolins, Zenons Narbuts, Arturs Truskovs, Maris Sperga, Haralds Plaudis. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia. World Journal of Surgery 2020; 44(2): 585 doi: 10.1007/s00268-019-05219-0
|
| 50 |
Min-Sun Kwak, Su Jin Chung, Jong In Yang, Jong Pil Im, Min Jung Park, Cheol Lee, Joo Sung Kim. Long-term Outcome of Small, Incidentally Detected Rectal Neuroendocrine Tumors Removed by Simple Excisional Biopsy Compared With the Advanced Endoscopic Resection During Screening Colonoscopy. Diseases of the Colon & Rectum 2018; : 1 doi: 10.1097/DCR.0000000000000905
|
| 51 |
Giovanna Muscogiuri, Luigi Barrea, Tiziana Feola, Marco Gallo, Erika Messina, Mary Anna Venneri, Antongiulio Faggiano, Annamaria Colao. Pancreatic Neuroendocrine Neoplasms: Does Sex Matter?. Trends in Endocrinology & Metabolism 2020; doi: 10.1016/j.tem.2020.02.010
|
| 52 |
Timothy L. Fitzgerald, Samuel O. Dennis, Swapnil D. Kachare, Nasreen A. Vohra, Emmanuel E. Zervos. Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?. Surgery 2015; 158(2): 466 doi: 10.1016/j.surg.2015.03.042
|